Vaxart, Inc. (VXRT)
0.631
-0.11
(-14.38%)
USD |
OTCM |
Mar 13, 16:00
Vaxart Shareholders Equity (Quarterly) : 87.80M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 24.10M |
| Nuwellis, Inc. | 2.63M |
| Capricor Therapeutics, Inc. | 305.79M |
| Allogene Therapeutics, Inc. | 292.54M |
| Silvergate Capital Corp. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 186.08M |
| Total Liabilities (Quarterly) | 98.28M |
| Debt to Equity Ratio | 0.1486 |
| Current Ratio | 1.603 |
| Net Debt Paydown Yield | 2.41% |